BioCentury
ARTICLE | Clinical News

TheraVida's Tolenix meets in Phase II for OAB

January 5, 2013 12:35 AM UTC

TheraVida Inc. (Mountain View, Calif.) said twice-daily Tolenix met the co-primary endpoints of reducing urination frequency and the number of incontinence episodes per day vs. placebo in a Phase II t...